Skip to main content

CalciMedica, Inc.

CALC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001534133

No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by CalciMedica, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for CalciMedica, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for CalciMedica, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Alafi Capital Co LLC10% Owner–Aug 24, 20261
Shaw AllanDirector–Aug 21, 20261
Glicklich AlanDirector–Aug 21, 20262
Guerard FredericDirector90,727Aug 21, 20261
Zaytsev EvgenyDirector–Aug 21, 20262
Wilson Robert NDirector1,604,650Aug 21, 20262
Hebbar SudarshanChief Medical Officer186,025Aug 21, 20263
Roberts Eric WCHIEF BUSINESS OFFICER366,435Aug 21, 20263
Leheny A. RachelCHIEF EXECUTIVE OFFICER317,655Aug 21, 20263
Middleton Fred ADirector, 10% Owner1,063,272IndirectJun 29, 20261
Bardin StephenChief Financial Officer3,000IndirectApr 7, 20261
Dunn Michael J.President and COO11,761Apr 7, 20261
Stauderman Kenneth A.Chief Scientific Officer12,944Apr 7, 20261
Sanderling Venture Partners VI Co Investment Fund LP10% Owner22,479IndirectNov 5, 20240
Sanderling Venture Partners VI LP10% Owner22,479IndirectNov 5, 20240
Sanderling VI Limited Partnership10% Owner22,479IndirectNov 5, 20240
Sanderling VI Beteiligungs GmbH & Co KG10% Owner22,479IndirectNov 5, 20240
Sanderling Ventures Management VI10% Owner22,479IndirectNov 5, 20240
Sanderling Ventures VII, L.P.10% Owner22,479IndirectNov 5, 20240
Sanderling Ventures VII Annex Fund, L.P.10% Owner22,479IndirectNov 5, 20240
Sanderling Ventures Management VII10% Owner22,479IndirectNov 5, 20240
Sanderling Ventures VII (Canada), L.P.10% Owner22,479IndirectNov 5, 20240
Bjerkholt EricDirector3,684Aug 28, 20240
Geffken Daniel E.Interim CFO–May 20, 20240
Valence Investments SPV IV LLC10% Owner316,109IndirectMay 3, 20230
Valence Investments SPV V, LLC10% Owner316,109IndirectMay 3, 20230
Valence Investments SPV VI, LLC10% Owner316,109IndirectMay 3, 20230
Shaffer Christy LDirector1,429Mar 27, 20230
Breuil Robert SChief Financial Officer35,326Mar 27, 20230
Eastland Julia MarieDirector1,429Mar 27, 20230
Ackermann ChristinaDirector1,429Mar 27, 20230
Zamiri ParisaChief Medical Officer28,982Mar 27, 20230
Sauer DirkDirector1,429Mar 27, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 29, 2026 (view filing)Jun 254 daysMiddleton Fred ADirector, 10% OwnerPPurchase+249.0K$0.80+$199.2K+30.6%1.06M after
Sep 22, 2025 (view filing)Sep 184 daysRoberts Eric WCHIEF BUSINESS OFFICERPPurchase+2.50K$3.07+$7.67K+3.1%84.2K after
Sep 17, 2025 (view filing)Sep 152 daysRoberts Eric WCHIEF BUSINESS OFFICERPPurchase+3.40K$2.68+$9.11K+4.3%81.7K after
Sep 15, 2025 (view filing)Sep 123 daysRoberts Eric WCHIEF BUSINESS OFFICERPPurchase+5.00K$3.12+$15.6K+6.8%78.3K after
Sep 11, 2025 (view filing)Sep 92 daysRoberts Eric WCHIEF BUSINESS OFFICERPPurchase+2.34K$3.15+$7.38K+3.3%73.3K after
Sep 2, 2025 (view filing)Aug 28-295 daysRoberts Eric WCHIEF BUSINESS OFFICERPPurchase+10.0K$2.85+$28.5K+16.4%70.9K after2 lots
Aug 25, 2025 (view filing)Aug 214 daysRoberts Eric WCHIEF BUSINESS OFFICERPPurchase+3.51K$2.79+$9.79K+6.1%60.9K after
Aug 21, 2025 (view filing)Aug 19-202 daysRoberts Eric WCHIEF BUSINESS OFFICERPPurchase+3.00K$2.74+$8.23K+5.5%57.4K after2 lots
Aug 21, 2025 (view filing)Aug 192 daysHebbar SudarshanChief Medical OfficerPPurchase+9.56K$2.82+$27.0K+18.4%61.5K after
Aug 19, 2025 (view filing)Aug 154 daysRoberts Eric WCHIEF BUSINESS OFFICERPPurchase+5.08K$2.90+$14.7K+10.3%54.4K after
Aug 18, 2025 (view filing)Aug 14-154 daysHebbar SudarshanChief Medical OfficerPPurchase+5.98K$2.74+$16.4K+13.0%52.0K after2 lots
Jul 29, 2025 (view filing)Jul 254 daysStauderman Kenneth A.Chief Scientific OfficerSSale−1.00K$3.65−$3.65K−100.0%0 after
Jul 29, 2025 (view filing)Jul 281 dayStauderman Kenneth A.Chief Scientific OfficerPPurchase+1.00K$3.96+$3.96K+8.4%12.9K after
Jul 23, 2025 (view filing)Jul 221 dayRoberts Eric WCHIEF BUSINESS OFFICERPPurchase+1.50K$3.78+$5.67K+3.1%49.3K after
Jul 22, 2025 (view filing)Jul 211 dayRoberts Eric WCHIEF BUSINESS OFFICERPPurchase+1.50K$3.37+$5.05K+3.2%47.8K after
Jul 21, 2025 (view filing)Jul 21Same dayLeheny A. RachelCHIEF EXECUTIVE OFFICERPPurchase+1.00K$3.40+$3.40K+40.0%3.50K after
Jul 18, 2025 (view filing)Jul 18Same dayWilson Robert NDirectorPPurchase+4.50K$2.87+$12.9K+1.1%422.0K after
Jul 18, 2025 (view filing)Jul 18Same dayRoberts Eric WCHIEF BUSINESS OFFICERPPurchase+2.00K$2.88+$5.76K+4.5%46.3K after
Jul 16, 2025 (view filing)Jul 142 daysRoberts Eric WCHIEF BUSINESS OFFICERPPurchase+6.50K$2.43+$15.8K+17.2%44.3K after
Jul 15, 2025 (view filing)Jul 141 dayLeheny A. RachelCHIEF EXECUTIVE OFFICERPPurchase+2.50K$2.47+$6.17KNew position2.50K after
Jul 10, 2025 (view filing)Jul 91 dayRoberts Eric WCHIEF BUSINESS OFFICERPPurchase+5.00K$1.60+$8.00K+15.2%37.8K after
Jul 2, 2025 (view filing)Jul 11 dayStauderman Kenneth A.Chief Scientific OfficerPPurchase+1.00K$1.85+$1.85KNew position1.00K after
Jun 27, 2025 (view filing)Jun 261 dayRoberts Eric WCHIEF BUSINESS OFFICERPPurchase+4.50K$1.44+$6.48K+15.9%32.8K after
Jun 26, 2025 (view filing)Jun 26Same dayBardin StephenChief Financial OfficerPPurchase+2.00K$1.50+$3.00K+200.0%3.00K after
Jun 13, 2025 (view filing)Jun 112 daysRoberts Eric WCHIEF BUSINESS OFFICERPPurchase+5.00K$1.85+$9.25K+21.4%28.3K after
Jun 9, 2025 (view filing)Jun 5-64 daysRoberts Eric WCHIEF BUSINESS OFFICERPPurchase+10.1K$1.74+$17.6K+76.4%23.3K after2 lots
Jun 3, 2025 (view filing)May 304 daysBardin StephenChief Financial OfficerPPurchase+1.00K$1.69+$1.69K+2.5%41.0K after
Dec 6, 2024 (view filing)Dec 6Same dayMiddleton Fred ADirector, 10% OwnerPPurchase+4.80K$2.65+$12.7K+15.1%36.5K after
Nov 6, 2024 (view filing)May 17, 2023539 daysRoberts Eric WCHIEF BUSINESS OFFICERPPurchase+3.00K$2.68+$8.04KNew position3.00K afterAmended
Nov 5, 2024 (view filing)3:08 PM ETNov 14 daysSanderling Venture Partners VI Co Investment Fund LP and 8 others10% OwnerPPurchase+86.9K$3.75+$325.8K+11.9%814.3K after
Nov 5, 2024 (view filing)3:08 PM ETNov 14 daysSanderling Venture Partners VI Co Investment Fund LP and 8 others10% OwnerPPurchase+877$3.75+$3.29K+4.1%22.5K after
Nov 5, 2024 (view filing)Nov 14 daysMiddleton Fred ADirector, 10% OwnerPPurchase+20.0K$3.75+$75.0K+170.7%31.7K after
Nov 5, 2024 (view filing)Nov 14 daysMiddleton Fred ADirector, 10% OwnerPPurchase+87.7K$3.75+$329.0KNew position22.5K after2 lots
Nov 1, 2024 (view filing)Nov 1Same dayLeheny A. RachelCHIEF EXECUTIVE OFFICERPPurchase+20.0K$3.75+$75.0K+18.0%130.9K after
Nov 1, 2024 (view filing)Nov 1Same dayRoberts Eric WCHIEF BUSINESS OFFICERPPurchase+53.3K$3.75+$200.0K+47.9%164.7K after
Nov 1, 2024 (view filing)Nov 1Same dayWilson Robert NDirectorPPurchase+53.3K$3.75+$200.0K+14.6%417.5K after
Aug 27, 2024 (view filing)Aug 27Same dayLeheny A. RachelCHIEF EXECUTIVE OFFICERPPurchase+1.00K$4.19+$4.19K+0.9%110.9K after
Aug 26, 2024 (view filing)Aug 233 daysRoberts Eric WCHIEF BUSINESS OFFICERPPurchase+5.00K$3.57+$17.9K+60.8%13.2K after2 lots
Aug 26, 2024 (view filing)Aug 233 daysWilson Robert NDirectorPPurchase+54.0K$3.72+$200.9K+17.4%364.2K after
Aug 22, 2024 (view filing)Aug 211 dayRoberts Eric WCHIEF BUSINESS OFFICERPPurchase+5.00K$4.04+$20.2K+12.5%44.9K after
Jul 2, 2024 (view filing)Jun 284 daysWilson Robert NDirectorPPurchase+51.3K$3.52+$180.5K+19.8%310.2K after
Jul 1, 2024 (view filing)Jun 274 daysWilson Robert NDirectorPPurchase+8.44K$3.23+$27.3K+3.4%258.9K after
Jun 28, 2024 (view filing)Jun 271 dayRoberts Eric WCHIEF BUSINESS OFFICERPPurchase+5.00K$3.22+$16.1K+95.7%10.2K after
Apr 2, 2024 (view filing)Apr 1-21 dayRoberts Eric WCHIEF BUSINESS OFFICERPPurchase+4.00K$3.90+$15.6K+11.1%39.9K after2 lots
Jan 25, 2024 (view filing)8:00 PM ETJan 232 daysMiddleton Fred ADirector, 10% OwnerPPurchase+679.4K$3.70+$2.52MNew position30.3K after7 lots
Jan 25, 2024 (view filing)8:00 PM ETJan 232 daysMiddleton Fred ADirector, 10% OwnerPPurchase+679.4K$0.125+$84.9K–14.4K afterDerivative14 lots
Jan 25, 2024 (view filing)8:00 PM ETJan 232 daysSanderling Venture Partners VI Co Investment Fund LP and 6 others10% OwnerPPurchase+243.4K$3.70+$900.9K+34.6%946.7K after
Jan 25, 2024 (view filing)8:00 PM ETJan 232 daysSanderling Venture Partners VI Co Investment Fund LP and 6 others10% OwnerPPurchase+436.0K$3.70+$1.61MNew position30.3K after6 lots
Jan 25, 2024 (view filing)8:00 PM ETJan 232 daysSanderling Venture Partners VI Co Investment Fund LP and 6 others10% OwnerPPurchase+243.4K$0.125+$30.4K–121.7K afterDerivative2 lots
Jan 25, 2024 (view filing)8:00 PM ETJan 232 daysSanderling Venture Partners VI Co Investment Fund LP and 6 others10% OwnerPPurchase+436.0K$0.125+$54.5K–14.4K afterDerivative12 lots